{
  "compound": "CBD-enriched cannabis extracts (artisanal)",
  "condition": "EPILEPSY",
  "effect_size": "Moderate (57% benefit)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:EPILEPSY_OBSERVATIONAL_002",
  "participants": "75 children with treatment-resistant epilepsy",
  "year": 2015,
  "notes": "Artisanal Cannabis for Pediatric Epilepsy: Multicenter Survey",
  "confidence": "medium",
  "abstract": "57% reported seizure improvement; 33% achieved \u226550% reduction; Dravet syndrome best responders (85%)"
}